Publikacje

Structure-activity relationship studies of CNS agents. Part 10(1): 1-Aryl-2-[3-(4-aryl-1-piperazinyl)propyl]-1,4-dihydro-3(2H)-isoquino linones: two modes of the interaction with the 5-HT1A receptor site. J L Mokrosz, A J Bojarski, M Maćkowiak, Z Bielecka, J Boksa
Die Pharmazie,
PMID:8016178
Poniedziałek, 25 Lipca 1994
Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain. V Klimek, J Zak-Knapik, M Mackowiak
Journal of psychiatry & neuroscience : JPN,
PMID:8148368
Piątek, 6 Maja 1994
Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes. A Czyrak, G Skuza, Z Rogóz, T Frankiewicz, J Maj
Arzneimittel-Forschung,
PMID:7511901
Środa, 4 Maja 1994
Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice. J Maj, Z Rogóz, G Skuza
Polish journal of pharmacology,
PMID:7906989
Wtorek, 5 Kwietnia 1994
Concomitant administration of MK-801 and desipramine enhances extracellular concentration of dopamine in the rat prefrontal cortex. K Wedzony, K Gołembiowska
Neuroreport,
PMID:8280864
Poniedziałek, 14 Lutego 1994
MK-801-induced symptoms of sensitization. The lack of correlation with the extracellular concentration of dopamine in the rat prefrontal cortex. K Wedzony, K Gołembiowska, V Klimek
Brain research,
PMID:8275316
Wtorek, 8 Lutego 1994
MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors. K Wedzony, V Klimek, K Gołembiowska
Brain research,
PMID:8242376
Czwartek, 6 Stycznia 1994
Enhancement by ipsapirone of dopamine release in the rat striatum. K Gołembiowska, K Wedzony
Polish journal of pharmacology,
PMID:7693136
Poniedziałek, 13 Grudnia 1993
Influence of 1,3-di-o-tolylguanidine and rimcazole, selective sigma ligands, on apomorphine and neuroleptic effects. J Maj, Z Rogóz, G Skuza
Polish journal of pharmacology,
PMID:8106091
Poniedziałek, 13 Grudnia 1993
Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity. J Maj, G Skuza, Z Rogóz
Journal of neural transmission. Parkinson's disease and dementia section,
PMID:8105798
Piątek, 10 Grudnia 1993